August 6, 2026
Funding Fusion News

Synthetic biology startup StrainX Bioworks raises $13 million to scale alternative protein production

  • May 25, 2026
  • 0

Indian artificial biology startup StrainX Bioworks has raised $13 million in a funding spherical co-led by Prime Enterprise Companions and Leo Capital. The spherical additionally included participation from Good

Synthetic biology startup StrainX Bioworks raises  million to scale alternative protein production


Indian artificial biology startup StrainX Bioworks has raised $13 million in a funding spherical co-led by Prime Enterprise Companions and Leo Capital.

The spherical additionally included participation from Good Startup, Sparrow Capital, Solar Icon Ventures, Dholakia Ventures and WindT Angels.

Based in 2023 by Akshay Mittal and Alok Malaviya, the Bhopal-based startup develops different proteins and different bio-based components utilizing artificial biology and precision fermentation applied sciences. Its merchandise are geared toward industries together with meals, vitamin, healthcare, agriculture, cosmetics and supplies.

It’s going to use the raised capital to broaden its analysis and improvement operations, scale up fermentation infrastructure and speed up industrial manufacturing in India and abroad markets, together with the US.

The startup has emerged from stealth mode after spending two years constructing capabilities in pressure engineering, fermentation and course of scale-up. It presently operates a bio-manufacturing facility in Bhopal with a fermentation capability of 10,000 litres, which it plans to extend tenfold over the subsequent two years.

A part of the funding may also be used to strengthen its Bengaluru analysis laboratory, rent extra scientists and broaden engineering groups. The startup presently employs round 100 individuals and plans to double its workforce by the top of the monetary 12 months.

Artificial biology includes engineering microorganisms resembling micro organism, yeast and fungi to provide proteins and different molecules historically sourced from vegetation or animals. These microbes are then scaled by industrial fermentation methods to fabricate components in managed environments.

Though the know-how has lengthy been utilized in prescription drugs, corporations are more and more exploring its functions in meals and shopper merchandise as manufacturing prices fall and demand for sustainable alternate options rises.

“Bio-manufacturing goes to outline the subsequent decade of producing,” Mittal mentioned.

“The final hundred years have been outlined by chemical manufacturing. Expertise has now superior to the purpose the place fermentation engineering and bio-manufacturing can produce issues cheaper and at higher high quality and value factors than older strategies,” he mentioned.